<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<title>Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity</title>
<style>
body { font-family: Arial, Helvetica, sans-serif; background:#0f1115; color:#e6e6e6; margin:0; padding:40px; }
.container { max-width:700px; margin:auto; background:#161a21; border-radius:10px; padding:32px; box-shadow:0 0 30px rgba(0,0,0,0.4); }
h1 { margin-top:0; color:#4da3ff; }
table { width:100%; margin-top:12px; border-collapse:collapse; }
th, td { text-align:left; padding:6px 8px; border-bottom:1px solid #2a2f3a; }
ul { margin-top:12px; padding-left:20px; }
.section { margin-top:24px; }
.small { margin-top:12px; font-size:13px; color:#999; }
a { color:#4da3ff; }
</style>
</head>
<body>
  <div class="container">
    <h1>Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity</h1>

    <table>
      <tr><th>Ticker</th><td>HIND</td></tr>
      <tr><th>Float</th><td>1.6 M</td></tr>
      <tr><th>IO</th><td>1.33%</td></tr>
      <tr><th>MC</th><td>14.6 M</td></tr>
      <tr><th>Extra Info</th><td>None</td></tr>
    </table>

    <div class="section">
      <strong>Summary</strong>
      <p>Vyome announced the publication of positive preclinical results for its candidate in uveitis, highlighting that the data support advancement toward addressing an estimated $3 billion market opportunity in ocular inflammatory disease. The release emphasizes favorable preclinical findings but does not announce human clinical trial results or new regulatory filings.</p>
    </div>

    <div class="section">
      <strong>Positives</strong>
      <ul><li>Company published positive preclinical data in uveitis</li><li>Targeting a large estimated ~$3 billion market opportunity in ocular inflammatory disease</li><li>Publication supports the scientific credibility of the program and potential progression toward development</li></ul>
    </div>

    <div class="section">
      <strong>Negatives</strong>
      <ul><li>Results are preclinical only (no human clinical data announced)</li><li>Press release does not disclose clinical timelines, regulatory pathway, or detailed study data</li><li>No SEC filing or financing information included in the announcement</li></ul>
    </div>

    <div class="section">
      <a href="https://www.businesswire.com/news/home/20260218057794/en/" target="_blank">Original Article</a>
    </div>

    <div class="small">HIND â€¢ TradersLink AI News</div>
  </div>
</body>
</html>